C-Rad AB (publ) (CRAD-B.ST)
SEK 29.9
(-0.17%)
SEK 29.9
(-0.17%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 404 Million SEK | 19.11% |
| 2022 | 339.17 Million SEK | 10.59% |
| 2021 | 306.7 Million SEK | 13.38% |
| 2020 | 270.52 Million SEK | 71.44% |
| 2019 | 157.79 Million SEK | 7.62% |
| 2018 | 146.61 Million SEK | 24.19% |
| 2017 | 118.05 Million SEK | 15.63% |
| 2016 | 102.1 Million SEK | 38.68% |
| 2015 | 73.62 Million SEK | 1.32% |
| 2014 | 72.66 Million SEK | 17.63% |
| 2013 | 61.77 Million SEK | 62.03% |
| 2012 | 38.12 Million SEK | -29.66% |
| 2011 | 54.2 Million SEK | -20.08% |
| 2010 | 67.82 Million SEK | 51.26% |
| 2009 | 44.83 Million SEK | -7.33% |
| 2008 | 48.38 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 450.1 Million SEK | -3.16% |
| 2024 Q2 | 464.8 Million SEK | 8.24% |
| 2024 Q1 | 429.4 Million SEK | 6.29% |
| 2023 Q4 | 404 Million SEK | 5.84% |
| 2023 Q3 | 381.7 Million SEK | 10.16% |
| 2023 Q2 | 346.5 Million SEK | 2.79% |
| 2023 Q1 | 337.1 Million SEK | -0.61% |
| 2023 FY | 404 Million SEK | 19.11% |
| 2022 Q3 | 312.9 Million SEK | 1.46% |
| 2022 Q1 | 301.5 Million SEK | -1.7% |
| 2022 FY | 339.17 Million SEK | 10.59% |
| 2022 Q2 | 308.4 Million SEK | 2.29% |
| 2022 Q4 | 339.17 Million SEK | 8.4% |
| 2021 Q4 | 306.7 Million SEK | 7.47% |
| 2021 FY | 306.7 Million SEK | 13.38% |
| 2021 Q2 | 278.5 Million SEK | 2.35% |
| 2021 Q3 | 285.4 Million SEK | 2.48% |
| 2021 Q1 | 272.1 Million SEK | 0.58% |
| 2020 FY | 270.52 Million SEK | 71.44% |
| 2020 Q1 | 243 Million SEK | 54.0% |
| 2020 Q2 | 229.3 Million SEK | -5.64% |
| 2020 Q3 | 252.9 Million SEK | 10.29% |
| 2020 Q4 | 270.52 Million SEK | 6.97% |
| 2019 Q4 | 157.79 Million SEK | -10.65% |
| 2019 Q2 | 178.2 Million SEK | 12.86% |
| 2019 Q1 | 157.9 Million SEK | 7.7% |
| 2019 FY | 157.79 Million SEK | 7.62% |
| 2019 Q3 | 176.6 Million SEK | -0.9% |
| 2018 Q3 | 117.3 Million SEK | -5.4% |
| 2018 Q2 | 124 Million SEK | 11.41% |
| 2018 Q1 | 111.3 Million SEK | -5.72% |
| 2018 FY | 146.61 Million SEK | 24.19% |
| 2018 Q4 | 146.61 Million SEK | 24.99% |
| 2017 Q1 | 99.83 Million SEK | -2.22% |
| 2017 Q4 | 118.05 Million SEK | 7.32% |
| 2017 FY | 118.05 Million SEK | 15.63% |
| 2017 Q3 | 110 Million SEK | 2.54% |
| 2017 Q2 | 107.27 Million SEK | 7.45% |
| 2016 FY | 102.1 Million SEK | 38.68% |
| 2016 Q4 | 102.1 Million SEK | 11.1% |
| 2016 Q2 | 86.81 Million SEK | 8.03% |
| 2016 Q1 | 80.36 Million SEK | 9.16% |
| 2016 Q3 | 91.9 Million SEK | 5.85% |
| 2015 Q1 | 68.58 Million SEK | -5.61% |
| 2015 FY | 73.62 Million SEK | 1.32% |
| 2015 Q4 | 73.62 Million SEK | 6.68% |
| 2015 Q3 | 69.01 Million SEK | -14.32% |
| 2015 Q2 | 80.54 Million SEK | 17.44% |
| 2014 Q3 | 65.68 Million SEK | -4.27% |
| 2014 Q4 | 72.66 Million SEK | 10.63% |
| 2014 Q1 | 66.22 Million SEK | 7.2% |
| 2014 FY | 72.66 Million SEK | 17.63% |
| 2014 Q2 | 68.61 Million SEK | 3.61% |
| 2013 Q1 | 39.74 Million SEK | 4.25% |
| 2013 Q4 | 61.77 Million SEK | 6.3% |
| 2013 FY | 61.77 Million SEK | 62.03% |
| 2013 Q2 | 59.65 Million SEK | 50.08% |
| 2013 Q3 | 58.11 Million SEK | -2.58% |
| 2012 Q4 | 38.12 Million SEK | 5.99% |
| 2012 Q3 | 35.96 Million SEK | -12.02% |
| 2012 FY | 38.12 Million SEK | -29.66% |
| 2012 Q1 | 47.05 Million SEK | -13.19% |
| 2012 Q2 | 40.88 Million SEK | -13.12% |
| 2011 Q4 | 54.2 Million SEK | 9.64% |
| 2011 FY | 54.2 Million SEK | -20.08% |
| 2011 Q1 | 60.01 Million SEK | -11.51% |
| 2011 Q2 | 50.77 Million SEK | -15.39% |
| 2011 Q3 | 49.43 Million SEK | -2.64% |
| 2010 FY | 67.82 Million SEK | 51.26% |
| 2010 Q3 | 66.22 Million SEK | -2.36% |
| 2010 Q1 | 53.72 Million SEK | 19.83% |
| 2010 Q2 | 67.81 Million SEK | 26.23% |
| 2010 Q4 | 67.82 Million SEK | 2.42% |
| 2009 Q4 | 44.83 Million SEK | 10.81% |
| 2009 Q2 | 38.97 Million SEK | -9.17% |
| 2009 Q1 | 42.91 Million SEK | -11.31% |
| 2009 FY | 44.83 Million SEK | -7.33% |
| 2009 Q3 | 40.46 Million SEK | 3.82% |
| 2008 FY | 48.38 Million SEK | 0.0% |
| 2008 Q4 | 48.38 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -542.453% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 87.711% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 87.711% |
| Arcoma AB | 81.96 Million SEK | -392.911% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | 40.839% |
| BICO Group AB (publ) | 10.19 Billion SEK | 96.038% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | 46.497% |
| CellaVision AB (publ) | 928.71 Million SEK | 56.499% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -599.87% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -1740.087% |
| Duearity AB (publ) | 15.14 Million SEK | -2567.723% |
| Dignitana AB (publ) | 44.83 Million SEK | -801.162% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -287.344% |
| Getinge AB (publ) | 55.09 Billion SEK | 99.267% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -293.615% |
| Iconovo AB (publ) | 128.07 Million SEK | -215.428% |
| Integrum AB (publ) | 164.85 Million SEK | -145.058% |
| Luxbright AB (publ) | 40.68 Million SEK | -892.954% |
| Mentice AB (publ) | 322.52 Million SEK | -25.261% |
| OssDsign AB (publ) | 356.38 Million SEK | -13.359% |
| Paxman AB (publ) | 167.12 Million SEK | -141.735% |
| Promimic AB (publ) | 92.87 Million SEK | -334.993% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -934.677% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -527.973% |
| ScandiDos AB (publ) | 81.47 Million SEK | -395.87% |
| Sectra AB (publ) | 3.21 Billion SEK | 87.418% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 60.16% |
| Senzime AB (publ) | 433.54 Million SEK | 6.814% |
| SpectraCure AB (publ) | 144.83 Million SEK | -178.94% |
| Stille AB | 804.89 Million SEK | 49.807% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 97.535% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 81.6% |